Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212

NCT01072175 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: GSK2118436
DRUG: GSK1120212

Sponsor

Novartis Pharmaceuticals